Institutional investors purchased a net $3.5 million shares of MRK during the quarter ended September 2015 and now own 75.70% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WELLINGTON MANAGEMENT CO. LLP Bought 8.7 Million shares of Merck
NEWTON INVESTMENT MANAGEMENT LTD... Bought 7.8 Million shares of Merck
BLACKROCK FINANCIAL MANAGEMENT, ... Bought 4.9 Million shares of Merck